StockVS

NASDAQ · Health Information Services · USD

So-Young International Inc. (SY) Stock Analysis

So-Young International Inc. (SY) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

SY

$2.76

−$0.06 (−2.13%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SY with… →

SY Key Statistics

As of Sep 4, 2026
Trading
Open
$2.81
Previous Close
$2.82
Day's Range
2.70–2.82
52-Week Range
1.28–4.75
Volume
343.20K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.13
Valuation
Market Cap
$277.70M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.17
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.36
Financials (FY)
Revenue (FY)
$1.52B+3.87%
Net Income (FY)
−$242.30M
Profit marginThe share of revenue left as profit after all costs and taxes.
−15.57%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
85.01M
1-Year Return
−20.23%
Dividend and dates
Earnings Date
November 23, 2026estimated
Avg Volume
561.94K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SY Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+7.81%
2025+219.00%
2024−32.08%
2023+0.00%
2022−59.56%
2021−71.29%
2020−9.08%
2019 (partial year)−32.86%

As of September 4, 2026.

SY Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.52B−$242.30M−15.9%
2024$1.47B−$589.53M−40.2%
2023$1.50B$21.28M1.4%
2022$1.26B−$65.55M−5.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.52B$727.69M−$266.47M−$242.30M−15.9%
2024$1.47B$899.11M−$84.48M−$589.53M−40.2%
2023$1.50B$953.69M−$61.05M$21.28M1.4%
2022$1.26B$864.58M−$102.81M−$65.55M−5.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SY Valuation vs Health Information Services Median

Median of 53 stocks
MetricSYHealth Information Services medianvs median
P/S ratio0.172.660.1x the median
Profit margin−15.57%0.00%15.6 pts below

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values So-Young International Inc. (SY) at $277.70M. It is classified in the Health Information Services industry, within the Healthcare sector. Headcount on file is 2,348.

SY last closed at $2.76 on September 4, 2026. That is −$0.06 (−2.13%) against the previous close. Over the past 52 weeks the price has ranged from $1.28 to $4.75. The latest close sits 115.62% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $1.52B. That is +3.87% against the prior fiscal year, when revenue was $1.47B. The same year closed with a net loss of $242.30M. Profit margin runs at −15.57%. That is 15.6 percentage points below the Health Information Services median of 0%. Trailing earnings per share are −0.36.

Across the 4 fiscal years on file, revenue moves from $1.26B in 2022 to $1.52B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 0.17 times revenue. On price-to-sales that is 0.1 times the Health Information Services median of 2.66. 53 Health Information Services companies report these metrics, and the medians quoted come from that group.

The reported beta is 2.13. Annualized volatility over the trailing 7 years is 80.62%. The trailing one-year price return is −20.23%. Across 5 years the annualized return works out at −10.85%.

Growth & Income

No dividend is on file for SY.

The strongest complete calendar year on file is 2025 at +219.00%; the weakest is 2021 at −71.29%. Of the 6 complete calendar years on file, 1 finished higher. So far in 2026 the price is +7.81%.

Peer Comparison

So-Young International Inc. (SY) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
So-Young International Inc. SY $277.70M
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B

The Health Information Services industry average P/E ratio is 41.1x. So-Young International Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

View all Health Information Services stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About So-Young International Inc.

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems for urological treatments, and hydrodynamic-assisted liposuction systems for plastic surgery, as well as pneumatic liquid spray devices skin cleansing. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Beijing, China.

Visit website →